Skip to main content

Prototype Prescribing Outlier Dashboard for Orchard 2000 Group

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Orchard 2000 Group is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Freeze sprays and gels 10 Rubefacients, topical NSAIDS, capsaicin and poultice 1,213 0.01 0.00 0.00 21.35
Titanium dioxide 1 Sunscreening preparations 11 0.09 0.00 0.00 20.20
Cefixime 2 Cephalosporins 12 0.17 0.00 0.01 17.34
Nystatin 7 Antifungal preparations 122 0.06 0.00 0.01 7.08
Hepatitis B 4 Vaccines and antisera 5 0.80 0.02 0.11 6.78
Chlohexidine gluconate (Emollient) 4 Emollients 363 0.01 0.00 0.00 6.72
Hydroxyzine hydrochloride 307 Antihistamines 2,069 0.15 0.03 0.03 4.61
Formoterol/glycopyrronium/budesonide 18 Corticosteroids (respiratory) 2,517 0.01 0.00 0.00 4.57
Benzoyl peroxide 57 Topical preparations for acne 146 0.39 0.08 0.07 4.54
Paraldehyde 7 Drugs used in status epilepticus 19 0.37 0.01 0.08 4.32

Prescribing where Orchard 2000 Group is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Cabergoline 0 Bromocriptine and other dopaminergic drugs 7 0.00 0.86 0.27 -3.17
    Influenza 0 Vaccines and antisera 5 0.00 0.88 0.28 -3.13
      Ivermectin 1 Topical preparation for rosacea 5 0.20 0.88 0.22 -3.04
      Furosemide 1,325 Loop diuretics 2,264 0.59 0.85 0.09 -3.02
      Folic acid 812 Drugs used in megaloblastic anaemias 3,095 0.26 0.69 0.16 -2.74
      Bisoprolol fumarate 3,071 Beta-adrenoceptor blocking drugs 6,394 0.48 0.65 0.08 -2.19
      Codeine phosphate 1 Cough suppressants 86 0.01 0.74 0.33 -2.19
      Omeprazole 1,525 Proton pump inhibitors 9,444 0.16 0.50 0.16 -2.08
      Salbutamol 4,200 Selective beta(2)-agonists 5,145 0.82 0.91 0.04 -2.02
      Finasteride 137 Male sex hormones and antagonists 230 0.60 0.82 0.11 -1.96